Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now

The time is now right for randomized trials of MDR-TB, say the authors, as the expansion of MDR-TB programs provides the setting in which trials can be implemented.

Detalles Bibliográficos
Autores principales: Mitnick, Carole D, Castro, Kenneth G, Harrington, Mark, Sacks, Leonard V, Burman, William
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062482/
https://www.ncbi.nlm.nih.gov/pubmed/17988168
http://dx.doi.org/10.1371/journal.pmed.0040292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062482/
https://www.ncbi.nlm.nih.gov/pubmed/17988168
http://dx.doi.org/10.1371/journal.pmed.0040292

Ejemplares similares